Skip to main content

Advertisement

Log in

Recommendations for the detection of latent tuberculosis infection in patients with immune-mediated inflammatory diseases candidates for anti-TNF therapy may not be applicable in all settings

  • Correspondence
  • Published:
Rheumatology International Aims and scope Submit manuscript

The Original Article was published on 06 July 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hacioglu A, Borekci S, Melikoglu M et al (2021) Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates. Rheumatol Int. https://doi.org/10.1007/s00296-021-04926-z (Online ahead of print)

    Article  PubMed  Google Scholar 

  2. Taxonera C, Ponferrada Á, Bermejo F, SEGURTB study group from GETECCU et al (2017) Early tuberculin skin test for the diagnosis of latent tuberculosis infection in patients with inflammatory bowel disease. J Crohns Colitis 11:792–800. https://doi.org/10.1093/ecco-jcc/jjx022

    Article  PubMed  Google Scholar 

  3. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM (2002) A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57(9):804–809. https://doi.org/10.1136/thorax.57.9.804

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10(11):1192–1204

    CAS  PubMed  Google Scholar 

  5. Piñeiro R, Mellado MJ, Cilleruelo MJ et al (2012) Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results? Eur J Pediatr 171:1625–1632. https://doi.org/10.1007/s00431-012-1783-8

    Article  PubMed  Google Scholar 

  6. Seddon JA, Paton J, Nademi Z et al (2016) The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection. Thorax 71(10):932–939. https://doi.org/10.1136/thoraxjnl-2015-207687

    Article  PubMed  Google Scholar 

  7. World Health Organization (2014) Guidance for national tuberculosis programme on the management of tuberculosis in children (second edition). Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748_eng.pdf?ua=1. Accessed 25 Jul 2021

  8. National Institute for Health and Care Excellence. Tuberculosis NICE guideline  Published: 13 January 2016.  http://www.nice.org.uk/guidance/ng33/resources/tuberculosis-prevention-diagnosis-management-and-service-organisation-1837390683589. Accessed 2 Aug 2021

  9. Berti E, Galli L, Venturini E et al (2014) Tuberculosis in childhood: a systematic review of national and international guidelines. BMC Infect Dis 14(Suppl 1):S3. https://doi.org/10.1186/1471-2334-14-S1-S3

    Article  PubMed  PubMed Central  Google Scholar 

  10. Riestra S, Taxonera C, Zabana Y et al (2021) Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease. Gastroenterol Hepatol 44(1):51–66. https://doi.org/10.1016/j.gastrohep.2020.04.006

    Article  PubMed  Google Scholar 

Download references

Funding

The article received no specific funding.

Author information

Authors and Affiliations

Authors

Contributions

CT, DO, and CA wrote the paper.

Corresponding author

Correspondence to Carlos Taxonera.

Ethics declarations

Conflict of interest

CT has served as a speaker, consultant, and advisory board member for MSD, Abbvie, Hospira, Pfizer, Takeda, Janssen, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, and Tillots. CA has served as a speaker for Janssen and has prepared promotional material for Falk Pharma. DO has no conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taxonera, C., Olivares, D. & Alba, C. Recommendations for the detection of latent tuberculosis infection in patients with immune-mediated inflammatory diseases candidates for anti-TNF therapy may not be applicable in all settings. Rheumatol Int 42, 1491–1492 (2022). https://doi.org/10.1007/s00296-021-04963-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04963-8

Navigation